Teva Canada Limited v. Nycomed Canada Inc. et al.

Drug: pantoprazole

In the Matter of Sandoz Canada Inc. Week of November 5, 2012 The Supreme Court has dismissed Teva’s application for leave to appeal. The Federal Court of Appeal upheld the Trial Judge’s decision striking certain claims from Teva’s action claiming damages pursuant to s. 8 of the NOC Regulations. A summary of the decision below can be found here.